Cyanotech Co. (OTCMKTS:CYAN) Short Interest Down 85.0% in August

Cyanotech Co. (OTCMKTS:CYAN) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totaling 653 shares, a drop of 85.0% from the August 15th total of 4,353 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 14,470 shares, the short-interest ratio is currently 0.0 days.

Cyanotech Trading Down 4.4%

CYAN stock opened at $0.49 on Friday. The company has a quick ratio of 0.39, a current ratio of 1.06 and a debt-to-equity ratio of 0.13. Cyanotech has a twelve month low of $0.23 and a twelve month high of $0.57. The company has a market cap of $3.52 million, a P/E ratio of -1.94 and a beta of 0.07. The business has a fifty day moving average of $0.50 and a 200-day moving average of $0.44.

Cyanotech (OTCMKTS:CYAN) last posted its quarterly earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter. Cyanotech had a negative return on equity of 0.86% and a negative net margin of 0.25%.

Cyanotech Company Profile

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.